These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25190097)

  • 21. Association study of energy homeostasis genes and antipsychotic-induced weight gain in patients with schizophrenia.
    Jassim G; Fernø J; Theisen FM; Haberhausen M; Christoforou A; Håvik B; Gebhardt S; Remschmidt H; Mehler-Wex C; Hebebrand J; Lehellard S; Steen VM
    Pharmacopsychiatry; 2011 Jan; 44(1):15-20. PubMed ID: 20821366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
    Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
    Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin to reduce weight gain and metabolic disturbance in schizophrenia.
    Faulkner G; Duncan M
    Evid Based Ment Health; 2015 Aug; 18(3):89. PubMed ID: 26081916
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.
    Kim SH; Ivanova O; Abbasi FA; Lamendola CA; Reaven GM; Glick ID
    J Clin Psychopharmacol; 2007 Aug; 27(4):365-8. PubMed ID: 17632220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.
    Hasnain M; Fredrickson SK; Vieweg WV
    J Psychopharmacol; 2011 Jun; 25(6):715-21. PubMed ID: 21169390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes, schizophrenia and metabolic effects of antipsychotic drugs.
    Gouveia C; Chowdhury TA
    Ment Health Today; 2013; ():24-7. PubMed ID: 24397022
    [No Abstract]   [Full Text] [Related]  

  • 31. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone.
    Montes JM; Rodriguez JL; Balbo E; Sopelana P; Martin E; Soto JA; Delgado JF; Diez T; Villardaga I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):383-8. PubMed ID: 17129654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
    Maayan L; Correll CU
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): rationale, objectives, design and sample description.
    Pina-Camacho L; Díaz-Caneja CM; Saiz PA; Bobes J; Corripio I; Grasa E; Rodriguez-Jimenez R; Fernández M; Sanjuán J; García-López A; Tapia-Casellas C; Álvarez-Blázquez M; Fraguas D; Mitjans M; Arias B; Arango C
    Rev Psiquiatr Salud Ment; 2014; 7(4):166-78. PubMed ID: 25440735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia and comorbid metabolic disorders.
    Henderson DC
    J Clin Psychiatry; 2005; 66 Suppl 6():11-20. PubMed ID: 16107179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.
    Devlin AM; Panagiotopoulos C
    Pharmacogenomics; 2015; 16(9):981-96. PubMed ID: 26107755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxin polymorphisms associated with metabolic disturbance in patients treated with antipsychotics.
    Munro J; Skrobot O; Sanyoura M; Kay V; Susce MT; Glaser PE; de Leon J; Blakemore AI; Arranz MJ
    J Psychopharmacol; 2012 Mar; 26(3):374-9. PubMed ID: 21693553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring for metabolic complications associated with atypical antipsychotics.
    Farver D
    S D J Med; 2005 Feb; 58(2):53-4. PubMed ID: 15756776
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study].
    Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C
    Recenti Prog Med; 2009 Feb; 100(2):103. PubMed ID: 19350804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.